Clinical Study

Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size

Table 1

Eligibility criteria for the study.

Children aged 6 to 14 years
Refractive error of spherical equivalent between −0.50 D and −6.00 D†‡
Astigmatism of −2.50 D or less
Best-corrected visual acuity of logMAR 0.1 or better in both eyes
No history of other ocular diseases (i.e., amblyopia, strabismus, cataract, glaucoma, and congenital retinal diseases)
In good general health with no history of significant cardiac, respiratory, or endocrine diseases
No allergy to atropine, tropicamide, and cyclopentolate
No current or previous use of atropine or pirenzepine, contact lenses, or other forms of treatment that might affect myopia progression
Willing to comply with the allocated treatment and follow-up schedule

logMAR = logarithm of the minimum angle of resolution. Refraction was measured with cycloplegicretinoscopy. Refractive error of the spherical equivalent was defined as spherical refraction plus half the cylinder refraction.